ArticleBlood advances2026

Chihara D, Steiner RE, Nair R, et al. Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas. Blood Adv. 2025;9(7):1485-1491.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.